Vor Biopharma VOR Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Liquidity | |||||
| Current ratio | 18.2×+13.0× | 5.2×-3.9× | 9×-9.0× | 18.1×-3.1× | |
| Per Share | |||||
| Book value per share | -$16.64+40.8% | -$28.14-1,354% | $2.24-64.6% | $6.34-2.0% | |
| Valuation | |||||
| Market capitalization | $784.61M+2,513% | $138.24M-9.5% | $152.76M-50.6% | $309.21M-28.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Vor Biopharma's ratios come from?
- Every ratio is computed from Vor Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.